Hyperglycemia induced by dexamethasone in metastatic renal cell carcinoma during medication review with follow up. A clinical Case
DOI:
https://doi.org/10.60103/phc.v27.e863Keywords:
kidney neoplasm; dexamethasone; hyperglycemiaAbstract
A case of dexamethasone-induced hyperglycemia in metastatic renal cell carcinoma is presented, identified during the Pharmacotherapeutic Follow-up Service using the Dáder Method provided at the pharmacy. Three negative outcomes associated with medication were identified during follow-up: two related to non-quantitative safety and one to quantitative ineffectiveness. The importance of collaborative work between the pharmacist and physician to improve clinical outcomes is highlighted, as well as the need for close monitoring of capillary blood glucose levels during dexamethasone therapy.
Downloads
References
Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, et al. Renal cell carcinoma: An overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022 Jun 20;39(3):2022.
Choueiri TK, Hessel C, Halabi S, Sanford B, et al. Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update. Eur J Cancer. 2018 May; 94:115–125. doi: https://doi.org/10.1016/j.ejca.2018.02.012
Ryken TC, McDermott M, Robinson PD, Ammirati M, et al. The role of steroids in the management of brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010 Jan;96(1):103–114. doi: https://doi.org/10.1007/s11060-009-0057-4
Brooks D, Schulman-Rosenbaum R, Griff M, Lester J, et al. Glucocorticoid-induced hyperglycemia including dexamethasone-associated hyperglycemia in COVID-19 infection: A systematic review. Endocr Pract. 2022 Nov;28(11):1166–1177. doi: https://doi.org/10.1016/j.eprac.2022.07.014
Holle LM, Puri S, Clement JM. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice. J Oncol Pharm Pract. 2016 Jun;22(3):511–516. doi: https://doi.org/10.1177/1078155215581524
Faus-Dáder MJ, Amariles-Muñoz P, Martínez-Martínez F. Atención Farmacéutica Servicios orientados al paciente. 2 ed. Granada: Editorial Técnica AVICAM; 2022. 453 p.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Alfonso Pereira-Céspedes

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
La revista Pharmaceutical Care España se publica bajo una licencia «Creative Commons, Reconocimiento, No Comercial y Compartir Igual 4.0 Internacional» (CC BY-NC-SA 4.0)», que permite a otros compartir el trabajo con un reconocimiento de la autoría del trabajo y la publicación inicial en esta revista (con excepción de los usos comerciales).
Los autores que publican en esta revista están de acuerdo con los siguientes términos:a) Los autores conservan los derechos de autor (derechos morales) y garantizan a la revista el derecho de ser el primer soporte documental publicado del trabajo.
b) Se permite y anima a los autores a difundir la versión del trabajo revisado por pares y aceptada para su publicación (por ejemplo, en repositorios institucionales o temáticos), recomendando hacerlo con la versión final del editor “pdf”, “html” o “xml”).



